Critical Review: TNF Pharmaceuticals (TNFA) versus Its Competitors
Risk and Volatility TNF Pharmaceuticals has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals’ peers have a beta of 1.29, indicating that their average share price is 29% more volatile than the S&P 500. Institutional and Insider Ownership 9.6% of TNF Pharmaceuticals shares […]
Risk and Volatility TNF Pharmaceuticals has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals’ peers have a beta of 1.29, indicating that their average share price is 29% more volatile than the S&P 500. Institutional and Insider Ownership 9.6% of TNF Pharmaceuticals shares […]
